These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1716949)
1. Cyclosporin A inhibits DNA synthesis by epidermal Langerhans cells. Haftek M; Urabe A; Kanitakis J; Dusserre N; Thivolet J Reg Immunol; 1990-1991; 3(5):236-41. PubMed ID: 1716949 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A does not modify Langerhans' cell number and distribution in normal human skin. Urabe A; Haftek M; Kanitakis J; Schmitt D; Thivolet J Acta Derm Venereol; 1989; 69(3):249-52. PubMed ID: 2566233 [TBL] [Abstract][Full Text] [Related]
3. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study. Bergfelt L Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956 [TBL] [Abstract][Full Text] [Related]
4. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088 [TBL] [Abstract][Full Text] [Related]
5. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814 [TBL] [Abstract][Full Text] [Related]